
### [MONDO:0005281](http://purl.obolibrary.org/obo/MONDO_0005281)
**Label:** gallbladder disease

**Subclasses:** [MONDO:0012366](http://purl.obolibrary.org/obo/MONDO_0012366) (GBD3), [MONDO:0012365](http://purl.obolibrary.org/obo/MONDO_0012365) (GBD2), [MONDO:0002857](http://purl.obolibrary.org/obo/MONDO_0002857) (gallbladder sarcoma), [MONDO:0002856](http://purl.obolibrary.org/obo/MONDO_0002856) (gallbladder rhabdomyosarcoma), [MONDO:0002518](http://purl.obolibrary.org/obo/MONDO_0002518) (gallbladder papillary neoplasm), [MONDO:0004858](http://purl.obolibrary.org/obo/MONDO_0004858) (occlusion of gallbladder), [MONDO:0004859](http://purl.obolibrary.org/obo/MONDO_0004859) (hydrops of gallbladder), [MONDO:0000972](http://purl.obolibrary.org/obo/MONDO_0000972) (gallbladder lipoma), [MONDO:0021416](http://purl.obolibrary.org/obo/MONDO_0021416) (polyp of gallbladder), [MONDO:0003303](http://purl.obolibrary.org/obo/MONDO_0003303) (neurofibroma of gallbladder), [MONDO:0006219](http://purl.obolibrary.org/obo/MONDO_0006219) (gallbladder small cell neuroendocrine carcinoma), [MONDO:0006218](http://purl.obolibrary.org/obo/MONDO_0006218) (gallbladder biliary intraepithelial neoplasia), [MONDO:0004115](http://purl.obolibrary.org/obo/MONDO_0004115) (gallbladder small cell carcinoma), [MONDO:0006217](http://purl.obolibrary.org/obo/MONDO_0006217) (gallbladder adenosquamous carcinoma), [MONDO:0000373](http://purl.obolibrary.org/obo/MONDO_0000373) (gall bladder carcinoma in situ), [MONDO:0005667](http://purl.obolibrary.org/obo/MONDO_0005667) (biliary dyskinesia), [MONDO:0002155](http://purl.obolibrary.org/obo/MONDO_0002155) (cholecystitis), [MONDO:0006216](http://purl.obolibrary.org/obo/MONDO_0006216) (gallbladder adenoma), [MONDO:0004875](http://purl.obolibrary.org/obo/MONDO_0004875) (xanthogranulomatous cholecystitis), [MONDO:0006699](http://purl.obolibrary.org/obo/MONDO_0006699) (choledocholithiasis), [MONDO:0006633](http://purl.obolibrary.org/obo/MONDO_0006633) (acalculous cholecystitis), [MONDO:0006215](http://purl.obolibrary.org/obo/MONDO_0006215) (gallbladder adenocarcinoma), [MONDO:0001487](http://purl.obolibrary.org/obo/MONDO_0001487) (intrahepatic gall duct cancer), [MONDO:0005346](http://purl.obolibrary.org/obo/MONDO_0005346) (gallstones), [MONDO:0003026](http://purl.obolibrary.org/obo/MONDO_0003026) (gallbladder angiosarcoma), [MONDO:0006698](http://purl.obolibrary.org/obo/MONDO_0006698) (cholecystolithiasis), [MONDO:0005742](http://purl.obolibrary.org/obo/MONDO_0005742) (emphysematous cholecystitis), [MONDO:0004474](http://purl.obolibrary.org/obo/MONDO_0004474) (gallbladder lymphoma), [MONDO:0006476](http://purl.obolibrary.org/obo/MONDO_0006476) (undifferentiated gallbladder carcinoma), [MONDO:0003364](http://purl.obolibrary.org/obo/MONDO_0003364) (gallbladder leiomyosarcoma), [MONDO:0003220](http://purl.obolibrary.org/obo/MONDO_0003220) (gallbladder carcinoma), [MONDO:0021253](http://purl.obolibrary.org/obo/MONDO_0021253) (gallbladder neoplasm), [MONDO:0012672](http://purl.obolibrary.org/obo/MONDO_0012672) (cholelithiasis), [MONDO:0000987](http://purl.obolibrary.org/obo/MONDO_0000987) (strawberry gallbladder), [MONDO:0021503](http://purl.obolibrary.org/obo/MONDO_0021503) (benign neoplasm of gallbladder), [MONDO:0002667](http://purl.obolibrary.org/obo/MONDO_0002667) (gallbladder signet ring cell adenocarcinoma), [MONDO:0004148](http://purl.obolibrary.org/obo/MONDO_0004148) (gallbladder papillary carcinoma), [MONDO:0004149](http://purl.obolibrary.org/obo/MONDO_0004149) (gallbladder pleomorphic giant cell adenocarcinoma), [MONDO:0005411](http://purl.obolibrary.org/obo/MONDO_0005411) (gallbladder cancer), [MONDO:0004067](http://purl.obolibrary.org/obo/MONDO_0004067) (gallbladder mucinous adenocarcinoma), [MONDO:0004484](http://purl.obolibrary.org/obo/MONDO_0004484) (gallbladder melanoma), [MONDO:0003297](http://purl.obolibrary.org/obo/MONDO_0003297) (gallbladder leiomyoma), [MONDO:0010939](http://purl.obolibrary.org/obo/MONDO_0010939) (low phospholipid associated cholelithiasis), [MONDO:0006220](http://purl.obolibrary.org/obo/MONDO_0006220) (gallbladder squamous cell carcinoma), 

**Mapped go classes:** [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0090554](http://purl.obolibrary.org/obo/GO_0090554) (phosphatidylcholine-translocating ATPase activity), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0009636](http://purl.obolibrary.org/obo/GO_0009636) (response to toxic substance), [GO:0008525](http://purl.obolibrary.org/obo/GO_0008525) (phosphatidylcholine transporter activity), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0046581](http://purl.obolibrary.org/obo/GO_0046581) (intercellular canaliculus), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0045332](http://purl.obolibrary.org/obo/GO_0045332) (phospholipid translocation), [GO:0015629](http://purl.obolibrary.org/obo/GO_0015629) (actin cytoskeleton), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0032782](http://purl.obolibrary.org/obo/GO_0032782) (bile acid secretion), [GO:0017127](http://purl.obolibrary.org/obo/GO_0017127) (cholesterol transporter activity), [GO:2001140](http://purl.obolibrary.org/obo/GO_2001140) (positive regulation of phospholipid transport), [GO:0042626](http://purl.obolibrary.org/obo/GO_0042626) (ATPase activity, coupled to transmembrane movement of substances), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0015562](http://purl.obolibrary.org/obo/GO_0015562) (efflux transmembrane transporter activity), [GO:0015462](http://purl.obolibrary.org/obo/GO_0015462) (ATPase-coupled protein transmembrane transporter activity), [GO:0055088](http://purl.obolibrary.org/obo/GO_0055088) (lipid homeostasis), [GO:0000329](http://purl.obolibrary.org/obo/GO_0000329) (fungal-type vacuole membrane), [GO:1903413](http://purl.obolibrary.org/obo/GO_1903413) (cellular response to bile acid), [GO:0008559](http://purl.obolibrary.org/obo/GO_0008559) (xenobiotic transmembrane transporting ATPase activity), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:1901557](http://purl.obolibrary.org/obo/GO_1901557) (response to fenofibrate), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0061092](http://purl.obolibrary.org/obo/GO_0061092) (positive regulation of phospholipid translocation), [GO:0032376](http://purl.obolibrary.org/obo/GO_0032376) (positive regulation of cholesterol transport), [GO:0019534](http://purl.obolibrary.org/obo/GO_0019534) (toxin transmembrane transporter activity), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:0071944](http://purl.obolibrary.org/obo/GO_0071944) (cell periphery), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- [GO:0046581](http://purl.obolibrary.org/obo/GO_0046581) (intercellular canaliculus) 53.57%
- [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion) 53.57%
- Thing 52.39%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) 38.93%
- [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) and [GO:0070161](http://purl.obolibrary.org/obo/GO_0070161) (anchoring junction) 38.93%
- [GO:0005912](http://purl.obolibrary.org/obo/GO_0005912) (adherens junction) and [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) 38.93%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005565](http://purl.obolibrary.org/obo/GO_0005565) (obsolete mitochondrial tRNA) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.93%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005564](http://purl.obolibrary.org/obo/GO_0005564) (obsolete cytosolic tRNA) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.93%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005563](http://purl.obolibrary.org/obo/GO_0005563) (obsolete transfer RNA) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.93%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005562](http://purl.obolibrary.org/obo/GO_0005562) (obsolete RNA) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.93%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005561](http://purl.obolibrary.org/obo/GO_0005561) (obsolete nucleic acid) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.93%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005559](http://purl.obolibrary.org/obo/GO_0005559) (obsolete ribozyme) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.93%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005558](http://purl.obolibrary.org/obo/GO_0005558) (obsolete minor histocompatibility antigen) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.93%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005557](http://purl.obolibrary.org/obo/GO_0005557) (obsolete lymphocyte antigen) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.93%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005555](http://purl.obolibrary.org/obo/GO_0005555) (obsolete blood group antigen) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.93%


